K-numberK254173
Device nameARTIS icono floor; ARTIS icono biplane; ARTIS icono ceiling; ARTIS pheno
ApplicantSiemens Medical Solutions USA, Inc.
Product codeOWB
Device classClass II
Decision dateApr 24, 2026
DecisionSubstantially Equivalent
Regulation892.1650
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The ARTIS icono/ARTIS pheno (VE50B) systems are dedicated angiography fluoroscopic X-ray systems for single-plane and biplane diagnostic imaging and interventional procedures. They enable cardiac angiography, neuro-angiography, general angiography, rotational angiography, multipurpose angiography, whole body radiographic/fluoroscopic procedures, image-guided surgery, and optional 3D reconstruction via DynaCT software.

Technological characteristics

The subject device updated system software from VE40A to VE50B with enhanced Peristepping/Perivision, new postprocessing algorithms (Advanced I-Noise and Extended Overlay Reference), updated ARTIS Touch UI, updated collimators, updated Common Application Hosting, updated user interface, updated ARTIS Profiles, updated imaging system PC hardware, and updated tilt table. For Nexaris Angio-CT configuration, software was updated from VD11D to VE50B with added hardware for CT gantry collision avoidance.

Test standards cited

Compliance with IEC 60601-1, IEC 60601-1-2, IEC 60601-1-3, IEC 60601-2-28, IEC 60601-2-43, IEC 60601-2-54, ISO 10993-1, ISO 14971, ISO 15223-1, ISO 20417, IEC 62304 (software lifecycle), and IEC 62366-1 (usability engineering), among others. Software testing per FDA's 'Guidance for the Content of Premarket Submissions for Device Software Functions' at Basic level of concern.

Substantial equivalence argument

The ARTIS icono/ARTIS pheno (VE50B) is substantially equivalent to the legally marketed predicate ARTIS icono/ARTIS pheno (VE40A) (K241572) because it maintains identical indications for use, identical device class and regulation, comparable technological characteristics with only software and hardware enhancements, and non-clinical performance data demonstrating the same safety and effectiveness profile without raising new safety or effectiveness issues.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →